{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:03:29Z","timestamp":1790705009322,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant thyroid lesions are the most common malignancy of the endocrine glands with increasing rates in the last two decades. Papillary thyroid cancer is the most common thyroid malignancy. In our study, we aimed to quantitatively evaluate the levels of DNA repair proteins MSH2, MLH1, MGMT, which are representative blocks of patients diagnosed with papillary carcinoma, chronic thyroiditis, or colloidal goiter. Total or subtotal thyroidectomy material of 90 patients diagnosed with papillary carcinoma, nodular colloidal goiter, or chronic thyroiditis between 2009 and 2012 were retrospectively evaluated. Tissue samples obtained from paraffin blocks were stained with MGMT, MSH2, MLH1 proteins and their immunohistochemistry was evaluated. Prepared sections were examined qualitatively by an impartial pathologist and a clinician, taking into account the staining method under the trinocular light microscope. Although there was no statistically significant difference in MGMT, MSH2, MLH1, follicular cell positivity, staining intensity, and immunoreactivity values, papillary carcinoma cases showed a higher rate of follicular cell positivity, and this difference was more pronounced between papillary carcinoma and colloidal goiter. In the MSH2 follicular cell positivity evaluation, the difference between chronic thyroiditis and colloidal goiter was significant (p\u2009=\u20090.023). The difference between chronic thyroiditis and colloidal goiter was significant in the MSH2 staining intensity evaluation (p\u2009=\u20090.001). The difference between chronic thyroiditis and colloidal goiter was significant in MLH1 immunoreactivity evaluation (p\u2009=\u20090.012). Papillary carcinoma cases were demonstrated by nuclear staining only for MSH2 and MLH1 proteins as opposed to hyperplastic nodules. The higher levels of expression of DNA repair genes in malignant tumors compared to benign tumors are attributed to the functional activation of DNA repair genes. Further studies are needed for DNA repair proteins to be a potential test in the development and progression of thyroid cancer.<\/jats:p>","DOI":"10.1038\/s41598-021-89403-0","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T10:09:20Z","timestamp":1620727760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter"],"prefix":"10.1038","volume":"11","author":[{"given":"Bahri","family":"Evren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ne\u015fe","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe \u00c7\u0131k\u0131m","family":"Sertkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6mercan","family":"Topalo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"89403_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40463-017-0247-6","volume":"47","author":"WW Kim","year":"2018","unstructured":"Kim, W. W., Ha, T. K. & Bae, S. K. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis. J. Otolaryngol. Head Neck Surg. 47, 4 (2018).","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"89403_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1590\/S0100-69912010000500002","volume":"37","author":"LR Souza","year":"2010","unstructured":"Souza, L. R. et al. Citophotometric expression of Caspase-3 in papillary thyroid carcinoma in nodular goiter colloid. Rev. Col. Bras. Cir. 37, 316\u2013322 (2010).","journal-title":"Rev. Col. Bras. Cir."},{"key":"89403_CR3","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1089\/thy.2019.0278","volume":"29","author":"WS Goldner","year":"2019","unstructured":"Goldner, W. S. et al. Molecular variants and their risks for malignancy in cytologically indeterminate thyroid nodules. Thyroid 29, 1594\u20131605 (2019).","journal-title":"Thyroid"},{"key":"89403_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/1078-0432.CCR-18-0841","volume":"25","author":"JH Yim","year":"2019","unstructured":"Yim, J. H. et al. Identification of tissue-specific DNA methylation signatures for thyroid nodule diagnostics. Clin. Cancer Res. 25, 544\u2013551 (2019).","journal-title":"Clin. Cancer Res."},{"key":"89403_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12885-017-3314-5","volume":"17","author":"C Lonjou","year":"2017","unstructured":"Lonjou, C. et al. Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation. BMC Cancer 17, 328 (2017).","journal-title":"BMC Cancer"},{"key":"89403_CR6","first-page":"81","volume":"17","author":"C Giaginis","year":"2011","unstructured":"Giaginis, C. et al. Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study. Med. Sci. Monit. 17, 81\u201390 (2011).","journal-title":"Med. Sci. Monit."},{"key":"89403_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3322\/caac.21439","volume":"68","author":"ND Perrier","year":"2018","unstructured":"Perrier, N. D., Brierley, J. D. & Tuttle, R. M. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J. Clin. 68, 55\u201363 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"89403_CR8","first-page":"7778","volume":"22","author":"R Zeng","year":"2018","unstructured":"Zeng, R. et al. Relationship between Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma in children and adolescents. Eur. Rev. Med. Pharmacol. Sci. 22, 7778\u20137787 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"89403_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1089\/thy.2006.16.633","volume":"16","author":"U Schagdarsurengin","year":"2006","unstructured":"Schagdarsurengin, U., Gimm, O., Dralle, H., Hoang-Vu, C. & Dammann, R. CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma. Thyroid 16, 633\u2013642 (2006).","journal-title":"Thyroid"},{"key":"89403_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.oraloncology.2006.05.007","volume":"43","author":"M Sawhney","year":"2007","unstructured":"Sawhney, M. et al. MGMT expression in oral precancerous and cancerous lesions: Correlation with progression, nodal metastasis and poor prognosis. Oral Oncol. 43, 515\u2013522 (2007).","journal-title":"Oral Oncol."},{"key":"89403_CR11","first-page":"2107","volume":"26","author":"I Ruschenburg","year":"2006","unstructured":"Ruschenburg, I., Vollheim, B., Stachura, J., Cordon-Cardo, C. & Korabiowska, M. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours. Anticancer Res. 26, 2107\u20132112 (2006).","journal-title":"Anticancer Res."},{"key":"89403_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cncr.23548","volume":"113","author":"H Guan","year":"2008","unstructured":"Guan, H. et al. Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer 113, 247\u2013255 (2008).","journal-title":"Cancer"},{"key":"89403_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1139\/o05-140","volume":"83","author":"H Soejima","year":"2005","unstructured":"Soejima, H., Zhao, W. & Mukai, T. Epigenetic silencing of the MGMT gene in cancer. Biochem. Cell Biol. 83, 429\u2013437 (2005).","journal-title":"Biochem. Cell Biol."},{"key":"89403_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1089\/thy.2007.0035","volume":"17","author":"DY Kang","year":"2007","unstructured":"Kang, D. Y. High prevalence of RET, RAS, and ERK expression in Hashimoto\u2019s thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid 17, 1031\u20131038 (2007).","journal-title":"Thyroid"},{"key":"89403_CR15","doi-asserted-by":"publisher","first-page":"62414","DOI":"10.18632\/oncotarget.18620","volume":"8","author":"X Lai","year":"2017","unstructured":"Lai, X., Xia, Y., Zhang, B., Li, J. & Jiang, Y. A meta-analysis of Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma risk. Oncotarget 8, 62414\u201362424 (2017).","journal-title":"Oncotarget"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89403-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89403-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89403-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:02:31Z","timestamp":1670054551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89403-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89403"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89403-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9932"}}